Poland, Sept. 29 -- Poland based Werfen Polska sp. z o.o. has secured contract from Uniwersytecki Szpital Kliniczny w Opolu for Laboratory reagents - Purchase and delivery of diagnostic materials for determining the activated clotting time (ACT) along with control materials and materials for blood clotting tests using the thromboelastometric method. The value of the contract is worth 31880 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....